The Euro-Learn initiative has been approved for another three years, the European Association of Nuclear Medicine (EANM) has announced.
The Euro-Learn project -- an acronym for "European Increasing Awareness of Nuclear Scintigraphy in Cardiac Amyloidosis" -- was established to help professionals working with cardiac amyloidosis patients at every stage of their career.
The program provides training to increase their awareness and improve the use of nuclear scintigraphy with bone-seeking radiopharmaceuticals in the diagnostic work-up, along with other multimodality imaging techniques.
The program is managed through the European School of Multimodality Imaging and Therapy in cooperation with Pfizer.
Full details on the project are available on EANM's website.
